Perspectives on Health Care
998 total results. Page 11 of 40.
Health Care Partner Stephanie Trunk and Senior Attorney Erin Atkins will present at the Association for Accessible Medicines’ Legal Town Hall 2021 on May 25, 2021.
Stephanie Trunk will speak at Dynamic Global Events’ virtual Rx Pricing and Reimbursement Summit on May 25, 2021.
Health Care Partner Debra Albin-Riley and Counsel Sarah Benator will present a webinar for the California Society for Healthcare Attorneys (CSHA) on May 26, 2021.
Chambers USA: America’s Leading Lawyers for Business has recognized 42 Arent Fox LLP attorneys as leaders in their field.
D. Jacques Smith, Alexander S. Birkhold, Randall A. Brater, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell, Mattie Bowden
Headlines that Matter for Companies and Executives in Regulated Industries
Similar to the laws of several other states, the North Dakota law contains three main disclosure requirements that apply to “drug manufacturers”
The National Law Journal spoke with Arent Fox Complex Litigation Practice Leader Jacques Smith last week about key trends in FCA enforcement for the Health Care industry.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell, Mattie Bowden
Headlines that Matter for Companies and Executives in Regulated Industries
Several recent surveys and reports by governance and trade associations provide a useful overview of the duties, roles, challenges, and internal relationships of the corporate general counsel, as well as governing board needs and priorities.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell, Mattie Bowden
Headlines that Matter for Companies and Executives in Regulated Industries
Join us for a lively discussion on areas of focus for life sciences companies under the new Biden Administration.
Join us for a virtual discussion of telehealth’s current state of play from a boots-on-the-ground provider perspective, as well as views from Capitol Hill and CMS.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
D. Jacques Smith, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries.
On Thursday, the Senate Finance Committee held a confirmation hearing for two of the most important health policy officials nominated by President Biden, Chiquita Brooks-LaSure (Administrator, Centers for Medicare and Medicaid Services) and Andrea Palm (Deputy Secretary).
Congress recently passed two bills that are designed to educate patients and prescribers about biosimilars and thereby encourage their use and to close a loophole in existing law that allows certain branded drugs to retain longer market exclusivity.
Health Care Practice Leader Douglas Grimm will present at the Virginia-DC HFMA Spring Education Virtual Conference on April 15, 2021, regarding the current state of CARES Act’s Provider Relief Fund.
Health Care Partner Stephanie Trunk is teaching a Lawline course titled “What the Biden Administration Means for Drug Pricing, Coverage and Reimbursement” on April 12, 2021, at 3:30pm ET.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
Hospitals everywhere in the United States should take note: CMS announced on March 26, 2020, that it is lifting its extended 30-day survey suspension for hospitals. Survey activity will now resume.
In recent years, the emergency medical services (EMS) sector has assumed a more central role in health care delivery, including care in the home and, in some cases, emergency department visit prevention.
D. Jacques Smith, Randall A. Brater, Alexander S. Birkhold, Michael F. Dearington, Mohammed T. Farooqui, Rebecca W. Foreman, Nadia Patel, Laura Zell
Headlines that Matter for Companies and Executives in Regulated Industries
Applicable drug manufacturers and group purchasing organizations that are subject to the reporting rules under the Open Payments System are reminded that March 31, 2021, is the final day to submit and attest to data for the June 2021 publication of Program Year 2020 data.
Texas Health and Human Services announced that beginning April 1, 2021, drug manufacturers who wish for their products to be added to the Texas Drug Code Index (the Texas Medicaid formulary) must create an electronic account.
Immediately at issue was Lilly and Company and Lilly USA’ refusal to sell covered outpatient drugs at the 340B Ceiling Price to contract pharmacies acting as agents for 340B Covered Entities. Several 340B Covered Entities had petition for a hearing by the ADR panel.